Evidence map›Paper›PMID 36909533›Full record

ArticleResearch square2023

Comparison of the AmpFire Multiplex HPV Assay to the Xpert HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation.

Sikhulile Moyo, Doreen Ramogola-Masire, Natasha Moraka, Leabaneng Tawe, Farzad Noubary, Kesego Motsumi, Godiraone Manowe, Boitumelo Zuze, Botshelo Radibe, Faith Tt Hungwe and 5 more

Open access · greenFull text readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Sikhulile MoyoBotswana Harvard Health Partnership.
Doreen Ramogola-MasireUniversity of Botswana.
Natasha MorakaBotswana Harvard Health Partnership.
Leabaneng TaweUniversity of Botswana.
Farzad NoubaryNortheastern University.
Kesego MotsumiBotswana Harvard Health Partnership.
Godiraone ManoweBotswana Harvard Health Partnership.
Boitumelo ZuzeBotswana Harvard Health Partnership.
Botshelo RadibeBotswana Harvard Health Partnership.
Faith Tt HungweRoyal Institute of Technology.
Terence MohammedBotswana Harvard Health Partnership.
Comfort MaphorisaBotswana Harvard Health Partnership.
Roger ShapiroHarvard T.H. Chan School of Public Health.
Simani GaseitsiweBotswana Harvard Health Partnership.
Rebecca LuckettBeth Israel Deaconess Medical Center.
Botswana Harvard AIDS Institute Partnership · BWUniversity of Botswana · BWHadassah Medical Center · ILHarvard University · USKTH Royal Institute of Technology · SEUniversidad del Noreste · MX

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Evaluation of triage strategies and screening intervals in a human papillomavirus based cervical cancer screening program in women living with human immunodeficiency virus in BotswanaK08CA271949 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Rebecca Luckett · 2022 to 2026
$1.3M
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV IncidenceK43TW012350 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI Sikhulile Moyo · 2022 to 2026
$682k
FIC NIH HHS K43 TW012350NCI NIH HHS K08 CA271949NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36909533
PMCPMC10002806
OpenAlexW4322770830

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.